Neurology News

WEST PALM BEACH, Fla. — Application of a machine learning model to databases of patients with multiple sclerosis expanded understanding of disease progression, according to a poster at ACTRIMS 2024.

ATLANTA — Primary care optometrists can manage patients with mild traumatic brain injury in their practices without the need for vision therapy equipment, Heidi Bell, OD, FAAO, FCOVD, said at SECO 2024.

The number one financial goal for most doctors is, by far, getting to a comfortable retirement on their own timeline and with the lifestyle they want.

WEST PALM BEACH, Fla. — In an open-label extension, treatment with ozanimod demonstrated sustained efficacy for disease progression in patients with relapsing multiple sclerosis, per research presented at ACTRIMS 2024.

WEST PALM BEACH, Fla. — Oral administration of vidofludimus calcium reduced fatigue over 14 days compared with placebo and may have a long-term positive effect in multiple sclerosis, according to a poster presented at ACTRIMS 2024.

High hourly heat exposure was associated with elevated risk for acute ischemic stroke, researchers reported in JAMA Network Open.

Quanterix Corp. has announced collaborations with several health systems with the goal of improving and simplifying Alzheimer’s disease diagnosis by expanding access to blood biomarker assays.

The FDA has declined to approve a new drug application for roluperidone to treat negative symptoms in individuals with schizophrenia.

Treatment with atogepant was safe, effective and well-tolerated over 12 weeks in those with episodic migraine who failed multiple conventional therapies, with significant reductions in mean monthly migraine days compared with placebo.

A firm specializing in brain-computer interface has received a U.S. patent for its Medusa Electrode, which translates specific neuromodulation connections into universal electroencephalography plugs.